[ad_1]
Anonymous sources familiar with Musk and his enterprises suggest an ongoing use of ketamine
Concerns over Elon Musk’s alleged drug use are surfacing, causing unease among executives and board members overseeing the companies he leads, according to a Wall Street Journal report.
Anonymous sources familiar with Musk and his enterprises suggest an ongoing use of ketamine, despite Musk stating last August that he holds a prescription for the drug as an antidepressant.
The report outlines a history of Musk’s alleged consumption of LSD, cocaine, ecstasy, and psychedelic mushrooms, primarily at private gatherings.
Responding to the claims, Musk’s lawyer emphasised that the billionaire undergoes regular and random drug testing at SpaceX, consistently passing without issue.
Musk’s public use of marijuana alongside podcaster Joe Rogan in 2018 triggered a review of his federal security clearance by the Pentagon due to his role as SpaceX’s CEO.
Elon Musk addressed the allegations on X (formerly Twitter), stating, “After that one puff with Rogan, I agreed, at NASA’s request, to do 3 years of random drug testing. Not even trace quantities were found of any drugs or alcohol.”
The report further suggested that Linda Johnson Rice, a Tesla director since 2017, chose not to seek reelection due to frustration with Musk’s behaviour and alleged drug use.
Elon Musk oversees a diverse portfolio of six companies: Tesla, SpaceX, X (formerly Twitter), The Boring Co., Neuralink, and xAI, an artificial intelligence startup. The revelation of Musk’s purported drug use adds a layer of scrutiny to the entrepreneur’s leadership across these ventures.
[ad_2]
Source link